The Fit After Baby randomized controlled trial: An mHealth postpartum lifestyle intervention for women with elevated cardiometabolic risk.
Jacinda M NicklasLaura PyleAndrey SoaresJennifer A LeifermanSheana S BullSuhong TongAnn E CaldwellKatherine KuhnLinda A BarbourPublished in: PloS one (2024)
There were no significant differences between groups for postpartum weight loss for the entire study population. Among those unaffected by the COVID pandemic, women randomized to the FAB program lost significantly more weight than those randomized to the T4B program. The mHealth FAB program demonstrated a substantial level of engagement. Given the scalability and potential public health impact of the FAB program, the efficacy for decreasing cardiometabolic risk by increasing postpartum weight loss should be tested in a larger trial.
Keyphrases
- weight loss
- randomized controlled trial
- quality improvement
- public health
- bariatric surgery
- phase iii
- study protocol
- open label
- double blind
- roux en y gastric bypass
- placebo controlled
- clinical trial
- social media
- systematic review
- cardiovascular disease
- polycystic ovary syndrome
- metabolic syndrome
- weight gain
- adipose tissue
- skeletal muscle
- pregnant women
- insulin resistance
- climate change